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The biosynthetic gene cluster for the dienoyltetramic
acid streptolydigin was identified and characterized
from the producer organism Streptomyces lydicus
NRRL2433. Sequence analysis of an 80.8 kb DNA
region revealed the presence of 38 ORFs, 29 of which
are probably involved in streptolydigin biosynthesis
and would code for all activities required for its
biosynthesis. Six insertional inactivation mutants
were generated in the sequenced region to prove its
involvement in streptolydigin biosynthesis, to define
the boundaries of the cluster, to functionally charac-
terize some genes, and to generate novel derivatives.
A model for streptolydigin biosynthesis is proposed
that includes a probable domain skipping in the
streptolydigin PKS and the participation of a free-
standing adenylation domain protein. Some bioactive
derivatives of streptolydigin with altered glycosyla-
tion pattern have been produced by combinatorial
biosynthesis showing a certain degree of flexibility
of the L-rhodinosyl transferase SlgG for the recogni-
tion of 2,3,6-trideoxyhexoses and 2,6-dideoxyhexo-
ses, both in D- and L-configuration.
INTRODUCTION
Streptolydigin (Figure 1), produced by Streptomyces lydicus
(Deboer et al., 1955), is a member of the tetramic acids family,
which includes compounds with a large spectrum of biological
activities such as antibiotic, antiviral, antifungal, and antitumor
(Royles, 1995). Streptolydigin is a potent antibiotic inhibitor of
bacterial RNA polymerase (RNAP), which interferes with RNA
chain elongation process and thus inhibits DNA transcription
(Siddhikol et al., 1969; von Meyenburg et al., 1978). Interest-
ingly, streptolydigin exhibits only limited cross-resistance with
rifampicin (Campbell et al., 2001) and no cross-resistance with
other inhibitors of RNAP such as microcin J25 (Yuzenkova
et al., 2002; Adelman et al., 2004) and sorangicin (Campbell
et al., 2005). Recent studies have allowed the unraveling of
the structural basis of inhibition of bacterial RNAP by streptoly-Chemistry & Biology 16, 1031digin and a definition of the ‘‘streptolydigin pocket’’ (Tuske et al.,
2005; Temiakov et al., 2005). In addition, early reports showed
that streptolydigin and structural analogs are potent inhibitors
of terminal deoxynucleotidyl transferase (TdT), an enzyme
poorly expressed in normal leukocytes but found in large
amounts in leukocytes from patients with acute lymphoblastic
leukemia or with rare cases of acute and chronic myelocytic
leukemia (Dicioccio and Srivastava, 1976; Dicioccio et al.,
1980). These reports point to a putative therapeutic value for
these streptolydigin structural analogs for the treatment of
leukemia exhibiting abnormal TdT activity. This positive effect
has been shown by nucleoside analog cordycepin, which
inhibits the activity of TdT and, in addition, shows cytotoxic
activity against TdT+ rather than TdT leukemic cells in vitro
(Kodama et al., 2000; Foss, 2000). TdT activity in leukemia
is associated with a poor prognosis in chemotherapy and
survival time.
Several studies regarding the biosynthesis of streptolydigin
have shown the incorporation of propionate, acetate, methio-
nine, and glutamic acid in the form of b-methylaspartate in the
main structure of the compound (Pearce et al., 1980; Pearce
and Rinehart, 1983; Chen and Harrison, 2004; Chen et al.,
2006). These studies point to a hybrid polyketide synthase non-
ribosomal peptide synthetase (PKS-NRPS) system for the
biosynthesis of streptolydigin, which has been followed by the
identification of a type II thioesterase gene (usually associated
to type I PKS systems) in S. lydicus and demonstrated to be
involved in streptolydigin biosynthesis (Yu et al., 2006). In addi-
tion, the biosynthesis of streptolydigin has been recently linked
to fatty acid biosynthesis through inactivation experiments of
fabCF genes in S. lydicus encoding an acyl carrier protein
(ACP) and a beta-ketoacyl-ACP synthase II, respectively,
belonging to a type II fatty acid synthase, that led to streptolydi-
gin-nonproducing mutants (Zhao et al., 2009).
Here we report the cloning and characterization of the
complete gene cluster for streptolydigin biosynthesis from
S. lydicus NRRL2433. Insertional inactivation experiments
provide evidence for the involvement of the identified genes in
streptolydigin biosynthesis and the boundaries of the gene
cluster. In addition, several glycosylated derivatives were gener-
ated by combinatorial biosynthesis after expressing deoxysugar
biosynthesis genes in a mutant in which all genes specifically
involved in the biosynthesis of L-rhodinose were deleted.–1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1031
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Streptolydigin BiosynthesisRESULTS
Isolation and Characterization of the Streptolydigin
Gene Cluster
A library of S. lydicus genomic DNA in cosmid pWE15 was
screened by in situ colony hybridization using as probes: (i) bor-
relidin PKS coding genes from Streptomyces parvulus Tu¨4055
(Olano et al., 2004), (ii) urdZ3 and urdQ genes fromStreptomyces
fradiae (Hoffmeister et al., 2000), and (iii) a gene encoding a thio-
esterase II (TEII) from S. lydicus (Yu et al., 2006). Using the PKS
probe, 12 positive clones were isolated and verified by Southern
hybridization. All clones initially identified overlapped and
defined a unique chromosomal region. Two of them, Slg9C7
and Slg6G6 (sharing a region of 2.9 kb), were selected for further
analysis. A 1.2 kb internal fragment to a PKS gene (as deduced
from partial sequencing) and shared by both cosmids
(Figure 2A) was subcloned into pOJ260 and the resultant
construct pOJ961 used for gene disruption in S. lydicus leading
to mutant SLM961. Ultra-performance liquid chromatography
(UPLC) analysis of cultures of S. lydicus wild-type strain and
SLM961 mutant revealed the latter to be a streptolydigin-non-
producer mutant (Figure 2B). Using the second probe (urdZ3
and urdQ genes), another group of nine cosmid clones was iden-
tified, some of them previously isolated when using the PKS
probe. In addition, the use of the third probe (TEII probe) against
both groups of cosmids revealed the presence of this gene in
cosmids Slg4A8 and Slg9C7. To test the involvement of
Figure 1. Structures of Streptolydigin, Streptolydi-
gin Aglycon, and Novel Glycosylated Derivatives
Slg4A8 in streptolydigin biosynthesis, a 627 bp
BamHI fragment internal to a PKS gene (Fig-
ure 2A) was used for gene disruption in S. lydi-
cus leading to mutant SLM4C1. This mutant
was also confirmed by UPLC analysis to be
a streptolydigin-nonproducer mutant (Fig-
ure 2B). These experiments demonstrated that
the cloned DNA region mapped in cosmids
Slg4A8, Slg9C7, and Slg6G6 was involved
in streptolydigin biosynthesis. However, se-
quence analysis showed the need for further
extension to the left-hand side of the region
because the biosynthetic gene cluster was not
completed in Slg4A8 (Figure 2A). A 3 kb BamHI
fragment from the border of Slg4A8 was used to
rescreen the library leading to the identification
of five new overlapping clones, one of which
(Slg6E5) was selected for further sequencing.
Finally, the nucleotide sequence of an 80,894
bp region was determined (EMBL accession
number FN433113). Sequence analysis and
alignment with related sequences in databases
revealed the presence of 38 open reading
frames (ORFs), all of them showing high G+C
content andG+Cbias in the third codon position
that is characteristic of Streptomyces genes.
Analysis of the deduced products of the different ORFs revealed
the similarities shown in Table 1.
Delimiting the Boundaries of Cluster
Twenty-nine ORFS covering a region of 74.5 kb (from slgR2 to
slgA1), putatively assigned as streptolydigin biosynthesis genes,
are flanked by nine ORFs (two at the left-hand side and seven at
the right-hand side) presumably involved in primary metabolism
and housekeeping (Figure 2A and Table 1). From these, orf1
to orf6 showed by BLAST analysis significant similarities to
related proteins from S. coelicolor A3(2) (SCO1090, SCO1092,
SCO1100, SCO1101,SCO1102, andSCO1103) andS. avermitilis
MA-4680 (SAV1492, SAV1494, SAV1499, SAV1500, SAV1501,
and SAV1502). Furthermore, they also share the same genetic
organization as in these two streptomycetes. orf7, orf8, and
orf9 deduced gene products did not show similarities to proteins
in databases that would suggest a role for these proteins in strep-
tolydigin biosynthesis (Table 1 and Figure 2A). Taken together all
this information, it was quite probable that all these orfswere not
participating in streptolydigin biosynthesis. In order to unequivo-
cally determine the boundaries of the cluster, orf2 on the left-
hand side and orf3 on the right-hand side were inactivated by
insertional inactivation. The resulting mutants SLM2A (orf2) and
SLMA3 (orf3) were found to synthesize streptolydigin at the
same level as S. lydicus (data not shown). These results provide
evidence that orf2 lies at the upstream end and orf3 at the down-
stream end of the streptolydigin gene cluster (Figure 2A).1032 Chemistry & Biology 16, 1031–1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved
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Streptolydigin BiosynthesisFigure 2. Genetic Organization of the Streptolydigin Gene Cluster and UPLC Analysis of S. lydicus Strains
(A) Genetic organization of the streptolydigin gene cluster. White arrows indicate genes not involved in streptolydigin biosynthesis. Black and gray arrows indicate
genes involved in streptolydigin biosynthesis. Gray arrows indicate genes deleted inmutant SLM7H13 and disrupted inmutants SLMX27, SLM4C1, and SLM961.
Slg6E5, Slg4A8, Slg9C7, and Slg6G6 represent cosmids containing the sequenced region. Asterisks show the BamHI fragments used for disruption in mutants
SLM4C1 and SLM961. BamHI sites are numbered. B: BglII, M: MfeI, N: NruI P: PstI and S: StuI sites used for cloning purposes.
(B) UPLC analysis of S. lydicus wild-type (WT) and mutant SLM961, SLM4C1, and SLMX27. AU: arbitrary units. 1: Streptolydigin.Hybrid PKS-NRPS System and Related Genes
Three ORFs, slgA1, slgA2, and slgA3, arranged head-to-tail and
transcribed in the same direction, would code for a type I PKS
containing a total of 34 individual domains organized into
a loading module and seven extender modules (Table 2 and
Figure 3). The slgA1 gene would code for the loading and three
extension modules. Because the loading module contains
a KSQ domain, the biosynthesis of streptolydigin might start
with a malonyl-CoA, which subsequently would be decarboxy-
lated (Bisang et al., 1999). The slgA2 and slgA3 genes would
code for the remainder streptolydigin PKS, SlgA2 and SlgA3,
containing two modules each (Table 2 and Figure 3). All PKS
extension modules contain conserved KS and ACP domains.
There are DH domains at modules 3, 5, and 6 with the conserved
active site (Table 2). The AT domains for these PKS extension
modules display the active site motif and also contain the
expected motifs for the selection of either malonyl-CoA or meth-
ylmalonyl-CoA as shown in Table 2 and Figure 3. All KR domains,
except that from module 7, contain the conserved LDD motif
characteristic for the B-type KRs (Caffrey, 2003). In addition,
this KR7 lacks the characteristic Lx(S,G)RxG motif (Scrutton
et al., 1990), possibly rendering this domain inactive.
Two ORFs, slgN1 and slgN2, that would code for proteins with
high similarity to NRPS, were found in the streptolydigin cluster.
SlgN2 shows high similarity to LipNrps from StreptomycesChemistry & Biology 16, 1031–1aureofaciens involved in the biosynthesis of the tetramic acid
a-lipomycin (Bihlmaier et al., 2006), and it also contains three
domains, condensation (C), adenylation (A), and peptidyl carrier
protein (PCP) (Figure 3). The C domain contains three of seven
core motifs described for these domains, C2 (RHDxLRTxF), C5
(IGxHVNTLPxR), and particularly C3 (VHHxVFDTVS), which is
the best-conserved core motif in all NRPSs (Marahiel et al.,
1997). In addition, the thiolation motif is also present in the
PCP domain (AxFFxLGGHSL). However, as it happens in
LipNrps, the A domain is shorter than previously described for
other NRPSs and it contains only four of ten core motifs
described for these domains: A3 (VACxFTSGSTGxPKG), A4
(FVxS), A7 (YRRTGEL), and A8 (GRxDxRVTVHGxPVQLDRLE)
(Marahiel et al., 1997). In particular, motif A2, especially con-
served in NRPSs, and motifs A6 and A9, involved in adenylation,
are absent in SlgN2 A domain. The absence of most of the
A domain core motifs make it impossible to predict the constitu-
ents of the substrate binding pocket by comparison to other
NRPS systems present in the available databases. slgN1
would code for a discrete NRPS A domain like those described
in leinamycin, clorobiocin, and coumermycin A1 gene clusters
(Tang et al., 2004a; Garneau et al., 2005). SlgN1 contains eight
of the ten core motifs mentioned before: A1 (LTYxAL), A2
(LKAGxGYTMLDP), A5 (NxYGPAE), A6 (GELxVxGxGLAHGYV),
A7 (YRTGDL), A8 (GRxDxQVKIRGxRVEPGEVE), A9 (LPxYMVP),044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1033
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Streptolydigin BiosynthesisTable 1. Proposed Functions for Streptolydigin Biosynthesis Genes
Gene aaa
Proposed Function in Streptolydigin
Biosynthesis
Closest Similar Protein, Origin, (% Identity / Similarity),
Accession Number
orf1 145b Putative glycerophosphoryl diester phosphodiesterase SAV1492,
S. avermitilis MA-4680, (72/80), BAC69202
orf2 128 Hypothetical protein SCO1092, S. coelicolor A3(2), (78/88), CAB95979
slgR2 943 LuxR family transcriptional regulator ORF4, Amycolatopsis orientalis, (39/54), ABM47005
slgN2 707 NRPS domains C, A, T LipNrps, S. aureofaciens, (43/54), ABB05101
slgL 280 Unknown Hypothetical protein LipX2, S. aureofaciens, (38/53), ABB05100
slgM 426 N-methyl transferase Acid7565, Solibacter usitatus Ellin6076, (34/50), ABJ88473
slgS7 218 dTDP-hexose 3,5-epimerase RmlC, Saccharopolyspora erythraea NRRL 2338, (53/65), CAM05586
slgS6 434 dNDP-hexose 3,4-dehydratase UrdQ, S. fradiae, (76/85), AAF72550
slgS5 340 dNDP-4-keto-6-deoxyhexose reductase med-ORF14, Streptomyces sp. AM-7161, (44/53), BAC79033
slgS4 338 dNDP-hexose 3-ketoreductase SchS1, Streptomyces sp. SCC 2136, (56/66), CAF31369
slgS3 450 dNDP-hexose 2,3-dehydratase Francci3_4134, Frankia sp. CcI3, (55/66), ABD13482
slgO2 413 Cytochrome P450 SACE5814, Saccharopolyspora erythraea NRRL 2338, (54/67),
CAM04998
slgC2 284 Unknown Putative secreted hydrolase SAMR0843, S. ambofaciens ATCC 23877,
(30/47), CAJ88552
slgG 391 Glycosyl transferase SnogD, S. nogalater, (40/53), AAF01811
slgZ 326 Aspartate-ammonia ligase PRK06462, Pyrobaculum aerophilum str. IM2, (52/69), AAL64277
slgE3 440 Ferredoxin-dependent glutamate synthase CmaqDRAFT1154, Caldivirga maquilingensis IC-167, (39/56), EAZ64261
slgN1 567 NRPS domain A CY0110_07826, Cyanothece sp. CCY0110, (43/63), EAZ87983
slgS2 328 dNDP-glucose 4,6 dehydratase GilE, S. griseoflavus, (72/83), AAP69571
slgS1 355 dNDP-D-glucose synthase StrD, S. griseus subsp. griseus, (71/84), CAH94331
slgE2 449 Glutamate mutase E-chain VinI, S. halstedii, (63/72), BAD08366
slgE1 153 Glutamate mutase S-chain VinH, S. halstedii, (63/77), BAD08365
slgY 699 Unknown ATP/GTP-binding protein SAV4016, S. avermitilis MA-4680, (64/75),
BAC71728
slgR1 220 TetR-family transcriptional regulator SAML0351, S. ambofaciens ATCC 23877, (60/74), CAJ89338
slgT 515 Transport integral membrane protein SAV3957, S. coelicolor A3(2), (55/69), CAC04255
slgO1 414 Putative cytochrome P-450 RubU, S. collinus, (51/62), AAM97370
slgX 515 Unknown Ent-copalyl diphosphate synthase Ent-cdps, Streptomyces sp.KO-3988,
(41/56), BAD86797
slgC1 300 Unknown Putative secreted hydrolase SCO0787, S. coelicolor A3(2), (36/50),
CAC14352
slgB 260 Type II thioesterase LeuTE, S. lydicus, (94/95), AAZ20309
slgA3 3477 PKS modules 6 and 7 Orf9, S. aizunensis, (54/65), AAX98184
slgA2 3479 PKS modules 4 and 5 CONE, S. neyagawaensis, (54/66), AAZ94390
slgA1 6171 PKS loading domain and modules 1-3 Orf11, S. aizunensis, (52/64), AAX98186
orf3 246 Putative integral membrane protein SCO1100, S. coelicolor A3(2),
(41/45), CAB95987
orf4 311 Putative integral membrane protein SAV1500, S. avermitilis MA-4680,
(70/81), BAC69210
orf5 220 Putative integral membrane protein SAML1091, S. ambofaciens ATCC
23877, (56/69), CAJ90077
orf6 242 Putative hydrolase SAV1502, S. avermitilisMA-4680, (67/75), BAC69212
orf7 132 Putative lyase SCO1893, S. coelicolor A3(2), (79/85), CAB46394
orf8 205 Putative TetR-family transcriptional regulator Orf1006, S. kanamyceticus,
(85/90), BAE95420
orf9 142b Conserved hypothetical protein SAMR0656, S. ambofaciens ATCC
23877, (71/82), CAJ88366
a Amino acids of the deduced protein.
b Incomplete.1034 Chemistry & Biology 16, 1031–1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved
Chemistry & Biology
Streptolydigin BiosynthesisTable 2. Conserved Motifs Found in PKS Proteins Involved in Streptolydigin Biosynthesis
KS Motif AT Motif DH Motif KR Motif ACP Motif
LD DTAQSSG LD GxSxG.HAFH LD LGxDS
M1 DTACSSS M1 (p) GxSxG.YASH M1 LxSRxG.LDD.GxGxxAxxxA M1 LGxDS
M2 DTACSSS M2 (a) GxSxG.HAFH M2 LxSRxG.LDD.GxGxxAxxxA M2 LGxDS
M3 DTACSSS M3 (p) GxSxG.YASH M3 LxxHxxxGxxxxP M3 LxSRxG.LDD.GxGxxNxxxA M3 LGxDS
M4 DTACSSS M4 (p) GxSxG.YASH M4 GxGRxV..LDD.GxGxxGxxxA M4 LGxDS
M5 DTGCSSS M5 (p) GxSxG.YASH M5 LxxHxxxGxxxxP M5 LxSRxA.LDD.GxGxxAxxxA M5 LGxDS
M6 DTACSSS M6 (a) GxSxG.HAFH M6 LxxHxxxGxxxxP M6 LxSRxA.LDD.GxGxxAxxxA M6 LGxDS
M7 DTACSSS M7 (a) GxSxG.HAFH M7a np np GxAxxAxxxA M7 IGxAS
Con.b DTACSSS Con.c GxSxG.HAFH Con.d LxxHxxxGxxxxP Con.e LxSRxG.LDD.GxGxxGxxxA Con. f LGxDS
Y S G A
KS: ketosynthase, AT: acyl transferase, a: malonyl-CoA specific, p: methylmalonyl-CoA specific, DH: dehydratase, KR: ketoreductase, ACP: acyl
carrier protein, np: not present.
a Inactive domain.
bConsensus sequence as determined by Aparicio et al. (1996).
cConsensus sequence as determined by Haydock et al. (1995) and Reeves et al. (2001).
dConsensus sequence as determined by Bevitt et al. (1992).
eConsensus sequence as determined by Scrutton et al. (1990) and Caffrey (2003).
f Consensus sequence as determined by Wakil (1989).and A10 (NGKLDR), lacking motifs A3 and A4, which implies that
a portion of the region between coremotifs A3 and A6, thought to
accommodate the binding pocket (Marahiel et al., 1997), is
absent. That is probably the reason why the signature sequence
found for the binding pocket (DALQIGGGFK) predicts the use of
valine as substrate with a similarity of 80% with previously
described sequences (Rausch et al., 2005).Chemistry & Biology 16, 1031In the streptolydigin gene cluster there are twoORFs, slgB and
slgL (Figure 2A), coding for enzymes related to the PKS-NRPS
system. The gene slgL would code for a protein with high simi-
larity to LipX2 from S. aureofaciens (Table 1) and to hypothetical
proteins from Streptomyces verticillus, Streptomyces collinus,
and Streptomyces griseus subspecies griseus. LipX2 has been
proposed to be involved in the adenylation of glutamic acidFigure 3. Proposed Pathway for Streptolydigin Biosynthesis
In bold, PKS domains that differ from the predicted model. LD: loading module, M: module, KS: ketosynthase, AT: acyl transferase, a: malonyl-CoA specific, p:
methylmalonyl-CoA specific, ACP: acyl carrier protein, DH: dehydratase, KR: ketoreductase, C: condensation, A: adenylation, PCP: peptidyl carrier protein.–1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1035
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Streptolydigin Biosynthesisbefore it is bound to the PCP of LipNrps during the biosynthesis
of a-lipomycin (Bihlmaier et al., 2006). The gene slgBwould code
for a type II thioesterase, which contains the characteristic
GHSMG-130 aa-PGGHF motif at the catalytic center (Kotowska
et al., 2002), and shows similarities to type II thioesterases from
other Streptomyces, in particular LeuTE from S. lydicus AS
4.2501 (Table 1) involved in the biosynthesis of streptolydigin
(Yu et al., 2006). Type II thioesterases have been proposed to
rid PKS and NRPS of aberrant acyl and peptidyl chains that
might otherwise block the enzyme complex (Heathcote et al.,
2001; Schwarzer et al., 2002).
Precursor Supply
Three genes in the cluster, slgE1, slgE2, and slgE3, are probably
involved in the biosynthesis of b-methylaspartic acid (Figure 3),
putative substrate for the NRPS (Chen and Harrison, 2004;
Chen et al., 2006). The amino acid sequences of SlgE1 and
SlgE2 showed significant similarities to VinH and VinI, S and E
subunits of a coenzyme B12-dependent mutase from Strepto-
myces halstedii. (Ogasawara et al., 2005). SlgE1 and SlgE2
are also similar to S and E subunits of glutamate mutases from
Actinoplanes friuliensis and Streptomyces ansochromogenes,
respectively (Heinzelmann et al., 2003; Li et al., 2005). SlgE3
shows high similarity to ferredoxin-dependent glutamate syn-
thases and a subunits of NADPH-dependent glutamate syn-
thases from different archaeas. SlgE3 might be involved in the
channeling of glutamate specifically for the biosynthesis of
streptolydigin.
Sugar Biosynthesis and Transfer
Several genes have been identified that might be involved in
L-rhodinose biosynthesis (Table 1, Figure 3). Two of them,
slgS1 and slgS2, that are located together and transcribed in
the same direction, would code for a dNDP-D-glucose synthase
and a dNDP-D-glucose 4,6-dehydratase respectively. SlgS1 and
SlgS2 contain ADP-glucose pyrophosphorylase (PDOC00638)
and short-chain dehydrogenase/reductases (PDOC00060)
conserved family signatures, respectively. In a different operon
and apparently transcribed together are five additional genes
slgS3, slgS4, slgS5, slgS6, and slgS7. SlgS3 shows strong simi-
larity to dTDP-2,3-glucose dehydratases, SlgS4 shows similarity
to 3-ketoreductases, which render hydroxyl groups at C-3 with
an equatorial configuration, SlgS5 is similar to different 4-ketor-
eductases. SlgS6 shows strong similarity to dTDP-3,4-glucose
dehydratases and SlgS7 resembles proteins that contain
conserved domains for dTDP-sugar-isomerases (Pfam00908)
and are proposed to act as 5- or 3,5-epimerases required for
the D-hexose to L-hexose switch (Salas and Me´ndez, 2005). In
another different operon there is an additional gene, slgG,
encoding a glycosyltransferase based in its similarities with other
known enzymes from the glycosyltransferase family 28 (Cou-
tinho et al., 2003). SlgG might be responsible for the transfer of
L-rhodinose to the streptolydigin aglycon.
Tailoring Modification
There are four genes in the cluster, slgO1, slgO2, slgZ, and slgM,
that would code for enzymes that might be involved in oxygena-
tion, amidation, and methylation steps required during the
biosynthesis of streptolydigin (Figure 3). SlgO1 and SlgO2 are1036 Chemistry & Biology 16, 1031–1044, October 30, 2009 ª2009similar to cytochrome P450 enzymes. Both contain the con-
served O2 binding site, LLxAGxxT, and the C-terminal heme
binding domain, FGxGxHxCxG, including the invariant cysteine
residue that is the heme iron ligand (PDOC00081) associated
with these enzymes (Mendes et al., 2005). SlgZ shows similarity
to archaeal asparaginyl-tRNA synthetase-like enzymes and, in
a similar manner to those proteins, it contains the catalytic
core of asparaginyl-tRNA synthetases but lacks the N-terminal
anticodon-binding site. This kind of truncated form of aspara-
ginyl-tRNA synthetases have been shown to produce aspara-
gine by amidation of aspartic acid (Roy et al., 2003). Based on
the similarities found in protein databases, SlgM might be the
methyltransferase responsible for methylation of the amino
group present in the side chain of the acyltetramic moiety after
its introduction by SlgZ. SlgM contains the methyltransferase-
11 signature domain (pfam08241) present in SAM-dependent
methyltransferases of this family of enzymes.
Regulation and Secretion
Two putative regulatory genes are located in the streptolydigin
gene cluster, slgR1and slgR2. SlgR1 is similar to TetR-family
transcriptional regulators from different streptomycetes. It
contains the characteristic N-terminal helix-turn-helix (HTH)
DNA binding domain signature present in all members of this
family of regulatory proteins (pfam00440). These regulatory
proteins generally act as repressors (Ramos et al., 2005), but
there are examples of TetR-positive regulators like AtrA from
S. griseus (Hirano et al., 2008). SlgR2 shows high similarity to
PikD and LipReg4 regulatory proteins from pikromycin and a-lip-
omycin gene clusters in S. venezuelae and S. aureofaciens,
respectively (Wilson et al., 2001; Bihlmaier et al., 2006). These
proteins are members of the large ATP-binding regulators of
the LuxR family (LAL) characterized by the presence of an
ATP-binding domain represented by discernible Walker A,
GxxGxGK, and Walker B, R/K-x(7-8)-h(4)-D, motifs (Walker
et al., 1982), and a C-terminal LuxR type HTH DNA binding motif
(PDOC00542). In addition, there are two TTA codons in slgR2,
whichmight imply an upper level of regulation during streptolydi-
gin production by some homolog to the pleiotropic regulatory
gene bldA encoding a tRNA-Leu (Chater and Chandra, 2008).
One gene in the cluster, slgT, is a candidate thought to be
involved in streptolydigin secretion outside the cell. SlgT is
similar to transmembrane efflux proteins and contains 14 puta-
tive transmembrane-spanning helices. It shows high similarity
to LipEx1, proposed to be involved in the export of tetramic
acid a-lipomycin (Bihlmaier et al., 2006).
Unknown Function
Four genes in the cluster would code for proteins with an unclear
role in streptolydigin biosynthesis. The slgC1 and slgC2 gene
products contain the characteristic glycosyl hydrolase family
16 signature domain EIDVxExxGxxP and EMDVxExxGxxP
(PDOC00794), respectively. They show similarity to putative
secreted hydrolases and endo-1,3-b-glucanases from different
Streptomyces sp. SlgX contains a terpene synthase signature
(PDOC00825) and shows similarity to an ent-copalyl diphos-
phate synthase from Streptomyces sp. KO-3988 (Table 1) and
other terpene cyclases. However, it lacks the characteristic
DDxxD or DxDD motif present in the A or B type of isoprenoidElsevier Ltd All rights reserved
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chelating a divalent metal ion (Dairi, 2005). Inactivation of slgX
was performed to verify its possible involvement in streptolydigin
biosynthesis. The resultant mutant SLMX27 was able to produce
the same yields of streptolydigin than S. lydicus (Figure 2B), indi-
cating that this gene is not essential for streptolydigin biosyn-
thesis in this strain. The slgY product shows similarity to ATP/
GTP-binding proteins that belong to superfamily I of DNA and
RNA helicases (COG3973). SlgY, like the other members of this
family, contains an ATP-binding domain composed of Walker
A and B motifs.
Rational Design of New Glycosylated Streptolydigins
Experiments were carried out to attempt the generation of novel
streptolydigin derivatives. For this purpose, the S. lydicusmutant
SLM7H13 was generated, causing the simultaneous deletion of
most of all genes involved in L-rhodinose biosynthesis, genes
slgS3 to slgS7 (Figure 3). Analysis of the products accumulated
by mutant SLM7H13 (Figure 4A) showed two novel compounds
with UPLC retention times of 5.7 min (compound 2) and
5.8 min (compound 3), with masses of 473 and 487m/z ([M+H]+),
respectively. According to these masses, these compounds
might lack the deoxyhexose moiety, as anticipated. The struc-
tural elucidation of both compounds was carried out using
one-dimensional (1D) 1H, two-dimensional (2D) 1H correlated
spectroscopy (COSY), 1H, 13C heteronuclear single quantum
coherence (HSQC)-edited and heteronuclear multiple bond
correlation (HMBC) nuclear magnetic resonance (NMR) experi-
ments. In the case of compound 3, we found analogous chemical
shifts and atom connectivities to the NMR data of reference
compound streptolydigin (1), but without resonances from the
Figure 4. UPLC Analysis of S. lydicus
Strains
UPLC analysis of S. lydicus strain SLM7H13 (A)
and expressing pEM4T8-12 (B), pFL844T (C),
pFL845T (D), and pLNBIVT (E). AU: arbitrary units.
sugar moiety. This allowed us to identify
compound 3 as streptolydiginone, the
streptolydigin aglycon (Figure 1; see
Table S1 available online). Product 2 has
an identical NMR spectrum to molecule
3, but lacking the resonance signal of
the methyl group located in the streptoly-
digin acyltetramic moiety side chain,
which allowed its characterization as
a demethyl derivative of streptolydigi-
none (Figure 1 and Table S2), which is in
agreement with the observed mass of
473 m/z ([M+H]+). Production of strepto-
lydigin in mutant SLM7H13 was restored
by introduction of plasmid pEM4T8-12
containing genes slgS3 to slgS7 under
the control of ermE* promoter (Figure 4B).
Mutant SLM7H13, lacking all L-rhodi-
nose specific biosynthesis genes but still
possessing an active SlgG glycosyltrans-
ferase, was now used as recipient host to independently express
plasmids directing the biosynthesis of different deoxyhexoses:
pFL844T (L-amicetose), pFL845T (D-amicetose), pLN2T (L-oli-
vose), pLNRT (D-olivose), and pLNBIVT (L-digitoxose). With
two of these plasmids (pLN2T and pLNRT) no modification of
the UPLC pattern was observed (data not shown). In contrast,
analysis of strains SLM7H13/pFL844T, SLM7H13/pFL845T,
and SLM7H13/pLNBIVT showed the appearance of several
new UPLC peaks (Figure 4). Strain SLM7H13/pFL844T (Fig-
ure 4C) showed the production of compounds 2 and 3, and the
novel compound 4 with a UPLC retention time of 6.48 min and
masses of 601 and 487 m/z [M+H]+, ions corresponding to the
unfragmented compound and the aglycon fragment, respec-
tively. Structural elucidation by NMR of compound 4 (Figure 1
and Table S3) showed a streptolydigin derivative containing
L-amicetose instead of L-rhodinose (streptolydigin LA, Figure 1).
Signals characteristic of the amicetose sugar are observed in the
1D 1H proton spectrum, and consistent connectivities were
found in the 2DCOSY, HSQC, and HMBC spectra. The presence
of the anomeric proton at 5.3 ppm correlating with the amicetose
proton 31 proves the union of the sugar moiety to the amide
group of the tetramic ring. The coupling constant between 30
and the axial proton 31 is 12 Hz, which clearly corresponds to
an axial-axial interaction. This means that the anomeric proton
is at an axial position, while the streptolydigin unity has to be
at an equatorial position, as expected for sterical reasons. Strain
SLM7H13/pFL845T (Figure 4D) showed the production of
compounds 2 and 3 and two novel compounds, 5 and 6, with
UPLC retention times of 5.73 and 6.48 min and masses of 617
and 601 m/z [M+H]+, respectively. In both cases, molecular
ions corresponding to fragments of those compounds lackingChemistry & Biology 16, 1031–1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1037
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Due to the low production of compound 5, we were unable to
characterize this compound at the structural level. However,
according to the observed masses, it might correspond to a
streptolydigin derivative containing a 2,6-dideoxyhexose, prob-
ably D-olivose (streptolydigin DO, Figure 1), because it has
been described that pFL845 can direct the biosynthesis of this
sugar in addition to D-amicetose (Pe´rez et al., 2005). Instability
of compound 6 allowed only partial structural elucidation.
Thus, the NMR spectra showed similar patterns and molecular
connectivity to compound 4, including the anomeric proton at
5.3 ppm and other sugar-related signals, which allowed to iden-
tify 6 as a streptolydigin derivative probably containing D-amice-
tose instead of L-rhodinose (streptolydigin DA, Figure 1). This
would be in agreement with the expected deoxyhexose synthe-
sized by this plasmid, D-amicetose (Pe´rez et al., 2005). Analysis
of the products accumulated by strain SLM7H13/pLNBIVT
showed the production of compounds 2 and 3, and a novel
compound 7 with the same retention time as 2 (Figure 4E) and
masses of 617 and 487m/z [M+H]+ corresponding to the unfrag-
mented compound and the aglycon fragment, respectively. We
were unable to separate compounds 7 and 2 for structural eluci-
dation. However, according to the masses observed, compound
7 might correspond to a streptolydigin derivative containing
a 2,6-dideoxyhexose, probably L-digitoxose (streptolydigin LD,
Figure 1), because it is the deoxyhexose whose biosynthesis is
directed by pLNBIV (Fischer et al., 2002).
After structural elucidation, compounds 3 (streptolydiginone)
and 4 (streptolydigin LA) were tested for their antibacterial
activity against S. albus in comparison with streptolydigin used
as a control. Streptolydiginone was weakly active, showing
only a narrow inhibition halo. In contrast, streptolydigin LA
showed an inhibition halo similar to that of streptolydigin, indi-
cating that this compound has similar antibacterial potency
(Figure 5).
DISCUSSION
The S. lydicus streptolydigin gene cluster consists of 29 ORFs:
19 coding for structural proteins, 2 for pathway regulatory
proteins, 3 involved in NRPS substrate supply, 1 involved in
streptolydigin secretion, and 4 with unknown function. These
genes are organized in at least eight transcriptional units. Genes
encoding all the activities that are required for streptolydigin
biosynthesis were identified within the gene cluster. The confir-
mation of the involvement of this cluster in streptolydigin biosyn-
thesis was achieved by inactivation of slgA1 and slgA3 genes,
coding for PKS enzymes. In addition, the boundaries of the
gene cluster were defined by inactivation of orf2 and orf3,
leading to the generation of mutants still producing streptolydi-
gin at the same level as the wild-type strain.
According to streptolydigin polyketide structure (Figure 1), 32
PKS domains were initially predicted, arranged in eight modules,
but 34 were found (Figure 3), one of which was inactive (KR at
module 7) (Table 2). The presence of a KSQ module in SlgA1
was predicted based on feeding experiments that showed the
incorporation of malonyl-CoA instead of acetyl-CoA as starter
unit (Chen and Harrison, 2004). There are two discrepancies in
the PKS, taking in consideration streptolydigin structure. SlgA11038 Chemistry & Biology 16, 1031–1044, October 30, 2009 ª2009contains an unexpected KR domain at module 1 that dramati-
cally changes the reduction pattern that might be necessary
for the correct cyclization to form the bicyclic ketal (Figure 3)
(Chen et al., 2006). In addition, DH domain in module 3 was
expected in module 2. This DH domain is supposed to be active,
because it contains the conserved active-site motif (Table 2). We
have initially considered the possibility that this DH domain acts
during module 2 and 3 extension cycles by a module-skipping
mechanism, as shown before in the case of epothilone PKS
(Tang et al., 2004b), thus introducing two double bonds because
the KR domains in modules 2 and 3 seem active even though
there is a nonconservative replacement in NADPH binding
motif in module 3 (Table 2). The presence of these double bonds
might require the introduction of a hydroxyl group at C-6 and the
oxidation of the C-2 hydroxyl to a keto group by one of the SlgO
monooxygenases. This would allow the correct cyclization to
form the bicyclic ketal by C-6 hydroxyl group attack over C-2
to form a hemi-ketal. Loss of water and attack of the C-8
hydroxyl group on the resulting oxonium ion might give the bicy-
clic ketal as proposed before (Chen et al., 2006) (Figure 3).
However, this mechanism does not agree with the previously
reported biosynthetic experiments using oxygen-18 that clearly
showed retention of both the C-6 and C-8 oxygen bonds from
propionate and acetate, respectively, in the ketal (Chen et al.,
2006). For this reason, the most plausible mechanism implies
the DH3 activity only in module 2, which will provide at the end
of M3 a product containing an intact C-O bond from acetate
at C-6 and a cis double bond between C-4 and C-5, and the
oxidation of the C-2 hydroxyl group to a ketone by the activity
of SlgO1 or SlgO2 (Figure 3). This mechanism is consistent
Figure 5. Bioactivity Testing of Streptolydigin (1), Streptolydiginone
(3), and Streptolydigin LA (4) against S. albus
Each paper disk was soaked with 2 mg of the corresponding compound dis-
solved in 15 ml methanol. Negative control (C) contained 15 ml methanol and
no antibiotic.Elsevier Ltd All rights reserved
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before (Chen et al., 2006).
The next step during the biosynthesis of streptolydigin
requires the incorporation of b-methylaspartic acid by a
NRPS module (Figure 3). Two proteins containing NRPS
domains were found in the streptolydigin gene cluster, SlgN2
containing C, A, and PCP domains, and SlgN1 containing
only an A domain. SlgN1 and SlgN2 lack some of the predicted
A domain core motifs (Marahiel et al., 1997), but all the motifs
are present in both proteins, which opens the possibility of
cooperation between these proteins for the introduction of
b-methylaspartic acid on the growing PKS chain. Additional
proteins could be involved in the adenylation process, like
SlgL due to its similarity to LipX2, involved in the biosynthesis
a-lipomycin at the level of adenylation of glutamic acid before
it is bound to the PCP of LipNrps (Bihlmaier et al., 2006). The
involvement of SlgL in the biosynthesis of streptolydigin by
perhaps a ternary complex together with SlgN1 and SlgN2 is
an issue that would require further experiments. The type II
thioesterase SlgB is in addition involved in the biosynthesis
of streptolydigin, probably with a PKS-NRPS editing role, as
previously proposed for other analogous enzymes (Heathcote
et al., 2001; Schwarzer et al., 2002), because its inactivation
in S. lydicus AS 4.2501 sharply reduced the production of
streptolydigin (Yu et al., 2006).
b-Methylaspartic acid derived from glutamate has been sug-
gested to be a precursor in streptolydigin biosynthesis (Chen
and Harrison, 2004; Chen et al., 2006), and therefore could be
the substrate for the NRPS. b-Methylaspartic acid might origi-
nate from glutamic acid by the glutamate mutase system
composed of SlgE1 and SlgE2, similar to that described in the
biosynthesis of friulimycin, nikkomycin, and vicenistatin (Hein-
zelmann et al., 2003; Li et al., 2005; Ogasawara et al., 2005).
The putative ferredoxin-dependent glutamate synthase coded
by slgE3 gene could be in charge of the specific supply of gluta-
mic acid from primary metabolism-derived 2-oxoglutarate and
glutamine (Kameya et al., 2007) to the biosynthesis of streptoly-
digin. SlgZ could be involved in the introduction of an amino
group based on its high homology to archaeal asparaginyl-
tRNA synthetase-like enzymes that, like SlgZ, contain the
catalytic core of asparaginyl-tRNA synthetases but lack the
N-terminal anticodon-binding site. These kind of truncated forms
of asparaginyl-tRNA synthetases have been shown to produce
asparagine by amidation of aspartic acid (Roy et al., 2003). By
analogy, SlgZmight carry out the biosynthesis of 3-methylaspar-
agine by amidation of 3-methylaspartate, as it has been shown
before for the biosynthesis of asparagine in Pyrococcus abyssi
(Roy et al., 2003). Then, the NRPS could incorporate b-methylas-
partate as a precursor of streptolydigin. After the release of the
nascent compound from the NRPS and its probable sponta-
neous cyclization to form the tetramic acid moiety following
a direct Claisen-like process—because a reductase domain
was not found in the streptolydigin gene cluster, which precludes
an aldol-like cyclization (Chen et al., 2006)—further modifica-
tions might occur. The biosynthesis might proceed through the
introduction of an epoxide group by a cytochrome P450, either
SlgO1 or SlgO2, followed by N-methylation by SlgM (Figure 3).
The production of demethyl-streptolydiginone and streptolydigi-
none, compounds 2 and 3, respectively (Figure 1), by strainChemistry & Biology 16, 1031–SML7H13 (Figure 4A) lacking genes slgS3 to slgS7 (Figure 2A),
points to the epoxidation and methylation occurring before
glycosylation takes place. The involvement of cytochrome
P450 in epoxidation pathways has been previously showed for
OleP andPimDduring oleandomycin and pimaricin biosynthesis,
respectively (Shah et al., 2000; Mendes et al., 2005). The
N-methylation process occurring after the introduction of the
epoxide moiety is supported by the isolation of compound 2
(Figure 1). However, the introduction of the N-methyl group on
b-methylaspartate once it is bound to the NRPS and before
its attachment to the nascent polyketide cannot be excluded,
because a similar situation has been proposed to occur to
glutamic acid during the biosynthesis of a-lipomycin (Bihlmaier
et al., 2006).
Final steps in the biosynthesis of streptolydigin should require
the introduction of an L-rhodinose moiety in the aglycon
(Figure 3). All genes required for the biosynthesis of this deoxy-
sugar are present in the cluster together with the glycosyltrans-
ferase SlgG responsible for the attachment of this 2,3,6-trideox-
yhexose to the streptolydigin aglycon. The participation of SlgC1
and SlgC2, putative endo-1,3-b-glucanases, in the glucose
supply for the biosynthesis of L-rhodinose cannot be discarded.
Recently the involvement of similar enzyme VldI, a 1,4-a-D-
glucan glucohydrolase, in the biosynthesis of validamycin has
been reported in Streptomyces hygroscopicus (Singh et al.,
2007).
The expression of different sets of genes involved in the
biosynthesis of several deoxyhexoses into a strain lacking all
genes involved in the biosynthesis of L-rhodinose led to the
generation of new glycosylated forms of streptolydigin. SlgG
has therefore been shown to possess a certain degree of
substrate flexibility regarding the deoxysugar, because it was
able to transfer, in addition to its usual substrate L-rhodinose,
some 2,3,6-trideoxyhexoses (L-amicetose and D-amicetose)
and, less efficiently, some 2-6-dideoxihexoses (probably D-oli-
vose and L-digitoxose). Nevertheless, SlgG does not seem to
be so flexible and efficient as other glycosyltransferases such
as ElmGT (Rodrı´guez et al., 2002; Lombo´ et al., 2004; Pe´rez
et al., 2005, 2006; Ramos et al., 2009), StfG (Olano et al.,
2008), AraGT (Luzhetskyy et al., 2007), LanGT3 (Zhu et al.,
2007), or UrdGT2 (Trefzer et al., 2002). This apparent lack of
efficiency of SlgG could be influenced by the low production of
unglycosylated compounds observed in mutant SLM7H13
(Figure 4A). The complementation of this mutant with L-rhodi-
nose biosynthetic genes in trans restored the production of
streptolydigin but not at the level of the wild-type strain
(Figure 4B). This decrease in production has been observed in
other S. lydicusmutants defective in genes involved in streptoly-
digin biosynthesis (data not shown), but not in mutants SLMX27
(Figure 2B), SLM2A, and SLM3A defective in genes not required
for streptolydigin biosynthesis in S. lydicus.
Bioactivity testing of the compounds purified in this work
showed that the removal of the deoxyhexose (streptolydiginone)
clearly decreases the antibacterial activity of the compound. In
contrast, substitution of L-rhodinose by L-amicetose does not
greatly affect the antibacterial activity, suggesting that the
change in the spatial orientation of the hydroxyl group at C4 of
the sugar skeleton does not affect the interaction with the RNA
polymerase.1044, October 30, 2009 ª2009 Elsevier Ltd All rights reserved 1039
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Streptolydigin is a potent inhibitor of bacterial RNA poly-
merase that shows limited cross-resistance with other
inhibitors of this enzyme. This effect makes streptolydigin
a good candidate for the development of new derivatives
with improved antibiotic activity because of the emergence
of multiresistant bacterial strains for which antibiotics in
current clinical use have limited efficacy. In addition,
because streptolydigin has no effect on eukaryotic RNA
polymerase and it was also described as a potential anti-
tumor agent, the opportunity for developing derivatives
with enhanced antitumor activity seems promising. The
characterization of the streptolydigin biosynthetic gene
cluster from S. lydicus NRRL2433 has shown that its tetra-
mic acid moiety is synthesized by a hybrid type I PKS-
NRPS systemwith some streaking features as the participa-
tion of a free-standing adenylation domain protein. The
identification of streptolydigin cluster has allowed, in addi-
tion, the production of several new derivatives, unglycosy-
lated and glycosylated, with alternative deoxyhexoses,
through combinatorial biosynthesis and opens up a way
for future studies aimed at engineering more potent analogs
of this compound.
EXPERIMENTAL PROCEDURES
Strains, Culture Conditions, and Plasmids
The bacterial strains used in this work were S. lydicus NRRL2433, streptolydi-
gin producer, Escherichia coli DH10B (Invitrogen), and ET12567 (pUB307)
(Kieser et al., 2000), used for subcloning, and E. coli XLI-Blue MR (Stratagene),
used to propagate a cosmid library. The growth medium for S. lydicus and
mutants was tryptone soya broth (TSB); A medium was used for sporulation
(Ferna´ndez et al., 1998) and R5A as production medium (Ferna´ndez et al.,
1998). Conjugation of Streptomyces mycelium was performed following stan-
dard procedures (Kieser et al., 2000). The E. coli media were those described
in the literature (Sambrook et al., 1989). When plasmid-containing clones
were grown, the medium was supplemented with the appropriate antibiotics:
100 mg/ml ampicillin, 20 mg/ml tobramycin, 25 mg/ml apramycin, 50 mg/ml
thiostrepton, 50 mg/ml hygromycin, 10 mg/ml tetracycline, 25mg/ml chloram-
phenicol, or 50 mg/ml nalidixic acid.
Plasmids used in this work were pSL1180 (AmershamPharmacia) for routine
cloning; pWE15 (Stratagene) for constructing the cosmid library; and pOJ260
(Bierman et al., 1992), pOJ260P (Olano et al., 2004), and pEM4T (Mene´ndez
et al., 2006) for gene replacement and gene expression, respectively. pCR-
BLUNT (Invitrogen) was used for cloning polymerase chain reaction (PCR)
products. pEFBA (Lozano et al., 2000) was the source of apramycin resistance
gene aac3(IV). pAR15AT (Lombo´ et al., 2006) was the source of apramycin
resistance gene aac3(IV), oriT, attB bacterial attachment site, and int gene
specifying site-integration function from bacteriophage fC31. pLHyg (Olano
et al., 2004) was used as donor of the hygromycin resistance gene hyg. Plas-
mids pFL844 and pFL845 (Pe´rez et al., 2005), pLN2 and pLNR (Rodrı´guez
et al., 2002), and pLNBIV (Fischer et al., 2002) direct the biosynthesis of deox-
ysugars L-amicetose, D-amicetose, L-olivose, D-olivose, and L-digitoxose,
respectively.
DNA Manipulation
DNA manipulations were performed according to standard procedures for
E. coli (Sambrook et al., 1989) andStreptomyces (Kieser et al., 2000). A cosmid
library ofS. lydicusNRRL2433 genomic DNAwas constructed. DNA fragments
obtained from a partial digestion with MboI were ligated to cosmid pWE15
digested with BamHI and in vitro packaged using the Gigapack III Gold Pack-
aging Extract Kit according to the manufacturer’s handbook (Stratagene). The
resulting E. coli transductants were picked and transferred to 96-well micro-1040 Chemistry & Biology 16, 1031–1044, October 30, 2009 ª2009titer plates containing Luria broth medium and ampicillin. Clones were replica
plated onto Luria agar plates containing ampicillin. After overnight growth at
37C, colonies were transferred to nylon membrane filters for in situ colony
hybridization analysis according to published methods (Sambrook et al.,
1989) and screened using labeled probes that were generated using the DIG
DNA labeling and detection kit (Roche).
DNA Sequencing and Analysis of the Streptolydigin Gene Cluster
Streptolydigin gene cluster was located in a DNA region delimited by a BamHI
fragment of 6.9 kb from cosmid Slg6E5 (sites 1–2, Figure 2A), cosmids Slg4A8
and Slg9C7, and an EcoRI-BglII fragment of 10.7 kb from cosmid Slg6G6,
being the EcoRI site from pWE15. DNA sequencing of this region (Figure 2A)
was performed on double-stranded DNA templates with the dideoxynucleo-
tide chain termination method (Sanger et al., 1977) and the Cy5 Autocycle
Sequencing Kit (Pharmacia Biotech). An Alf-express automatic DNA
sequencer (Pharmacia) was used. Computer-aided database searching and
sequence analysis were carried out with the University of Wisconsin Genetics
Computer Group software (Devereux et al., 1984) and the BLAST program
(Altschul et al., 1997). Analysis of PKS and NRPS predicted proteins were
carried out using programs ASMPKS (Tae et al., 2007) and NRPSpredictor
(Rausch et al., 2005). Analysis of transmembrane regions in putative
membrane proteins were carried out using the program TMHMM v. 2.0 (Krogh
et al., 2001).
Construction of Plasmids for Gene Inactivation and
Complementation of Mutants
Involvement of PKS genes in streptolydigin biosynthesis was achieved by
gene disruption. For this purpose, two constructions, pOJ4C1 and pOJ961,
were generated in the Streptomyces-suicide vector pOJ260 (Bierman et al.,
1992). Plasmid pOJ4C1 and pOJ961 were obtained by cloning a 627 bp
BamHI fragment from cosmid Slg4A8 (sites 17–18, Figure 2A) and a 1.2 kb
BamHI fragment from cosmid Slg9C7 (sites 30–31, Figure 2A), respectively.
Plasmids pOJ4C1 and pOJ961 were used for generation of S. lydicus strains
SLM4C1 and SLM961.
The boundaries of the gene cluster were determined by inactivation of orf2
and orf3 by gene replacement. For inactivation of orf2, a 1.5 kb BamHI-PstI
fragment from cosmid Slg6E5 was subcloned into the same sites of pHyg
leading to pHyg2. After BglII digestion of pHyg2 (BglII restriction site is internal
to orf2, Figure 2A) and treatment with the Klenow fragment, the aac(3)IV gene
from pEFBA was subcloned as a SmaI-EcoRV fragment leading to pHyg2A.
For inactivation of orf3, a 1.9 kb StuI-PstI fragment from cosmid Slg6G6 was
subcloned into EcoRV-PstI-digested pHyg leading to pHyg3. After BamHI
digestion of pHyg3 (BamHI restriction site is internal to orf3, site 32,
Figure 2A) and treatment with the Klenow fragment, the aac(3)IV gene from
pEFBA was subcloned as a SmaI-EcoRV fragment leading to pHyg3A. Finally,
a 1 kb XbaI-SpeI fragment from pOJ260 containing the oriT was subcloned
into XbaI-digested pHyg2A and pHyg3A to obtain plasmids pHyg2AT and
pHyg3AT, respectively, that were used for generation of S. lydicus strains
SLM2A and SLM3A.
Inactivation of gene slgX coding for a putative ent-copalyl diphosphate syn-
thase of unknown function was accomplished by amplification of a slgX
internal fragment of 700 bp by PCR from cosmid Slg4A8 using oligoprimers
CRIS23 (50-AAA AAG CTT ACG CAC GGT TGG CCG CCC-30, HindIII under-
lined) and CRIS24 (50-AGA ATT CTG CTG CCG CTC CC CCA GC-30, EcoRI
site underlined). PCR conditions used were 97C, 5 min; 30 cycles of 95C,
30 s, 50C, 45 s, and 68C, 1 min, and a final extension cycle at 68C,
10 min. Pfx DNA polymerase (Invitrogen) and 2.5% dimethylsulfoxide
(DMSO) were used for all amplifications. The PCR product was cloned into
pCR-BLUNT and then sequenced. The resultant plasmid was digested
HindIII-EcoRI and the 700 bp fragment cloned into pOJ260 to obtain plasmid
pOJX27 used for generation of S. lydicus strain SLMX27.
For deletion of genes slgS3 to slgS7, all presumably involved in the biosyn-
thesis of the deoxysugar L-rhodinose, plasmid pOJ7H13 was constructed.
For that purpose, gene slgO2was amplified by PCR as a 1.2 kb fragment using
oligoprimers CRIS13 (50-AAG GAT CCG GCT CCG CGA TGA GCG AG-30,
BamHI site underlined) and CRIS14 (50-AGA ATT CAT GCA TGG TGG TCA
TCC GCC GCC-30, EcoRI site underlined and NsiI site in bold). Gene slgM
was amplified by PCR as a 1.3 kb fragment using oligoprimers CRIS17Elsevier Ltd All rights reserved
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and CRIS18 (50-AGA ATT CAC TAG TTC CTC GCC GGG CGT CAC-30, EcoRI
site underlined and SpeI site in bold). PCR conditions for both amplifications
were as described above. Both PCR products were cloned in pCR-BLUNT
and sequenced. Afterwards, gene slgM was cloned as a BamHI-EcoRI frag-
ment into BamHI-EcoRI-digested pOJ260P (Olano et al., 2004), where it will
be located downstream of ermE* promoter leading to plasmid pOJPM. Gene
slgO2was then cloned into BamHI-PstI-digested pLHyg as a BamHI-NsiI frag-
ment leading to construct pL7H, which was later on digested with HindIII and
SpeI for cloning a HindIII-SpeI fragment of 1.5 kb from pOJPM, containing
slgM and ermE* promoter, leading to construct pL7H13. In the former plasmid,
hyg gene is flanked by slgO2 upstream and slgM downstream, being slgM
under the control of ermE* promoter in order to avoid possible polar effects
in mutant strain SLM7H13. Finally, plasmid pL7H13 was digested with NheI
and SpeI and the resultant 4.3 kb fragment cloned into XbaI-digested
pOJ260, leading to construct pOJ7H13, which was used to generate S. lydicus
strain SLM7H13.
Plasmid pEM4T8-12 was constructed for complementation of S. lydicus
strain SLM7H13 by cloning a NruI-MfeI fragment of 6.9 kb, containing genes
slgS3 to slgS7 from cosmid Slg4A8, into a SmaI-MfeI-digested pSL1180
leading to plasmid pSL8-12, which was digested with EcoRI and MfeI and
the resultant fragment cloned into EcoRI-digested pEM4T. In construct
pEM4T8-12, genes slgS3 to slgS7 are under the control of ermE* promoter.
Plasmids pFL844T, pFL845T, pLN2T, pLNRT, and pLNBIVT are the integra-
tive version of plasmids pFL844, pFL845, pLR2, pLNR, and pLNBIV. These
integrative plasmids were constructed by cloning in an XbaI site of plasmids
pFL844, pFL845, pLR2, pLNR, and pLNBIV a 6.2 kb SpeI fragment from
plasmid pAR15AT (Lombo´ et al., 2006) containing the aac3(IV) and int genes,
the attB site, and the oriT RK2 region. Before SpeI digestion, the orip15A
region from pAR15AT was deleted by removing a 700 bp PstI-BglII blunt-
ended fragment followed by religation.
Generation of S. lydicus Mutant Strains
Constructs pOJ4C1, pOJ961, pHyg2AT, pHyg3AT, pOJX27, and pOJ7H13
were introduced into S. lydicus by intergeneric conjugation from E. coli
ET12567 (pUB307). Transconjugant S. lydicus strains SLM4C1, SLM961, and
SLMX27 were selected for resistance to apramycin, and integration in the
S. lydicus chromosome was verified by Southern hybridization. For generation
of S. lydicus strain SLM7H13, a single-crossover strain, apramycin and
hygromycin resistant, was cultured in absence of selection and then screened
for the lost of apramycin resistance, keeping hygromycin resistancebecause of
adouble recombination event. Thedeletion of genes slgS3 to slgS7wasverified
by Southern hybridization. For the generation of S. lydicus strains SLM2A and
SLM3A, a single-crossover strain, apramycin and hygromycin resistant, was
cultured in absence of selection and then screened for the loss of hygromycin
resistance, keeping apramycin resistance because of a double recombination
event. The inactivation of orf2 in SLM2A and orf3 in SLM3A was verified by
Southern hybridization. Plasmids pEM4T, pEM4T8-12, pFL844T, pFL845T,
andpLNBIVTwere introduced inS. lydicusSLM7H13by intergenic conjugation
and transconjugants were selected for resistance to thiostrepton.
Analysis of Streptolydigin Production by UPLC and LC-MS
Streptolydigin production was assessed by growing S. lydicuswild-type strain
or mutant strains on solid R5A medium. After 7 days at 30C, agar plugs con-
taining 1.5 ml agar media were extracted with 1 ml ethyl acetate and the pres-
ence of streptolydigin in the extract analyzed by UPLC as described below. In
liquid cultures, strains were grown as a seed culture in TSB (30 ml in a 250 ml
Erlenmeyer flask). After 2 days incubation in a rotary incubator (30C; 250 rpm),
2.5%v/v of the cultureswas used to inoculate 30ml R5A liquidmedium. After 7
additional days of incubation with shaking, the cultures were harvested for
analysis. One milliliter aliquots of fermentation broths were removed and
300 ml ethyl acetate was added to the sample and then mixed vigorously for
30 min. The phases were separated by centrifugation in a microfuge and
then the ethyl acetate removed by evaporation using a Speed-Vac. Residues
were resuspended in methanol and clarified by centrifugation. Analysis of
streptolydigin production was performed by reversed phase chromatography
on Acquity UPLC equipment with a BEH C18 column (2.13 100 mm, Waters),
with acetonitrile and 0.05% trifluoroacetic acid (TFA) as solvents. SamplesChemistry & Biology 16, 1031–were eluted with 10% acetonitrile for 1 min, followed by a linear gradient
from 10% to 80% acetonitrile over 7 min, at a flow rate of 0.5 ml/min and
a column temperature of 30C. For HPLC-MS analysis, an Alliance chromato-
graphic system coupled to a ZQ4000mass spectrometer and a Symmetry C18
(2.1 3 150 mm, Waters) was used. Solvents were the same as above and
elution was performed with an initial isocratic hold with 10% acetonitrile for
4 min followed by a linear gradient from 10% to 88% acetonitrile over
26 min, at 0.25 ml/min. MS analyses were done by electrospray ionization in
the positive mode, with a capillary voltage of 3 kV and a cone voltage of
20 V. Detection and spectral characterization of peaks was performed in
both cases by photodiode array detection and Empower software (Waters),
extracting bidimensional chromatograms at 360 nm.
Isolation of Streptolydigin Novel Derivatives
For structural characterization compounds 2, 3, 4, and 6were purified from 10 l
cultures of the corresponding S. lydicus mutants following the culture condi-
tions described above. The extracts were dissolved in 5 ml of a mixture of
DMSO and methanol (1:1) and centrifuged, and the resulting upper lipid layer
was removed. The first purification step was done by chromatography in an
XTerra PrepRP18 column (19 3 300 mm, Waters) with acetonitrile and
0.05% TFA in water as solvents. A linear gradient from 30% to 100% acetoni-
trile in 7 min followed by a 3 min isocratic hold with 100% acetonitrile was
used, at a flow rate of 15 ml/min. Peaks of interest were collected in 0.1 M
phosphate buffer (pH 7.0). The solutions obtained were partially evaporated
in rotavapor to reduce the acetonitrile concentration and then applied to
a solid-phase extraction cartridge (Sep-Pak C18, Waters), washed with water
to remove salts, and eluted with methanol. Further purifications were per-
formed in isocratic conditions with a Symmetry C18 column (7.8 3 300 mm,
Waters), using mixtures of acetonitrile and 0.05% TFA in water optimized for
each peak, at a flow rate of 7 ml/min. As described above, peaks were always
collected on buffer, desalted by solid-phase extraction, and finally lyophilized.
NMR Spectroscopy
Final identification was carried out by 1H- and 13C-NMR experiments. Sample
preparation was done by dissolving 100–500 mg pure products in 200 ml
DMSO-d6 and transferred to a 3mm NMR tube. Solvent signals were used
as internal reference. NMR spectra were recorded at 300 K using a Bruker
Avance Ultrashield Plus 600 spectrometer equipped with a 5 mm TCI cryo-
probe. Homonuclear 2D 1H, 1H COSY and heteronuclear 1H, 13C HSQC/
HMBC experiments were acquired. Typical parameters for 2D experiments
were as follows: COSY, 256 and 2048 points in F1 and F2, respectively, 16 tran-
sients each; HSQC, 256 and 2048 points in F1 and F2, respectively, 48
transients each; HMBC, 512 and 2048 points in F1 and F2, respectively, 64
transients each. NMR spectra were processed using the program Topspin
1.3 (Bruker GmbH, Karlsruhe, Germany).
The information regarding structural characterization of compounds 2, 3,
and 4 is supplied as Tables S1, S2, and S3.
Bioactivity Testing
The antibiotic activity of streptolydigin, streptolydiginone (compound 3), and
streptolydigin LA (compound 4) was analyzed via antibiotic disc diffusion
assay. To do this, a spore suspension of S. albus was spread in a Petri dish
containing tryptone soy agarmedium (Merck). Paper disks of 5mm in diameter
were used. Each disk contained a solution of 2 mg of each compound dissolved
in 15 ml methanol. Fifteen microliters of methanol were used as negative
control. The antibiotics were allowed to diffuse from the disk at 4C during
2 hr and then the plates were incubated at 30C for 24 hr.
SUPPLEMENTAL DATA
Supplemental Data include three tables and can be found with the
article online at http://www.cell.com/chemistry-biology/supplemental/S1074-
5521(09)00325-1.
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